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Uterine Artery Embolization in The Treatment of Symptomatic Leiomyoma: 
Effect  on Ovarian Function, Clinical Symptoms and Its Complications
Introduction: The present study evaluated the effect of uterine artery embolization on 
preservation of fertility in leiomyoma and its complications. 
Materials/Methods: Thirty women with leiomyoma were included in the present 
study. Hormonal levels, leiomyoma size, patients’ symptoms and complications if 
developed were  evaluated, both before and after uterine artery embolization. 
Results: There was no significant difference between the mean follicle-stimulating 
hormone, luteinizing hormone and estradiol levels, before and after uterine artery 
embolization (p=0.431, p=0.672, p=0.772, respectively). Fibroids size measured before 
and after 6 months of uterine artery embolization UAE were 86.47 ± 28.42 cm and 
59.80 ± 20.90 cm, respectively (p<0.001). None of the patients developed complica-
tions such as embolism, wound problems or necessity for hysterectomy. After uterine 
artery embolization, symptoms such as hypermenorrhea, dysmenorrhea, dyspareunia, 
and dysuria decreased significantly among patients.
Conclusion: Spiral computed tomography has a good sensitivity and specificity for the 
diagnosis of pulmonary embolism. In the majority of patients who did not have pulmo-
nary embolism, it provided important ancillary information for the final diagnosis. 
Therefore, combining Spiral computed tomography scan with a D-dimer Test is more 
effective in the accurate diagnosis of pulmonary embolism.
INTRODUCTION
Uterine leiomyoma is a problem that arises in some women 
of childbearing age (Payson M 2006). Uterine leiomyoma 
(fibroma) can result in various symptoms such as severe 
bleeding, pain, compression and reduced fertility amidst 
women. Of all the hysterectomy cases done in United States 
annually, 30-40% have been related to this disease (Jacoby 
VL 2009). Hysterectomy or myomectomy, has been 
recognized traditionally as the primary approach for this 
disease, however, these surgical procedures cannot be 
performed in all the women (Bulman JC 2012). Moreover, 
these surgeries have many complications. 
       Uterine artery embolization (UAE) is a new therapeutic 
option that blocks blood flow to the uterus thereby reducing 
the size of fibroids. However, some evidences suggest that 
results with regard to the women fertility are better after 
myomectomy, than UAE (Ravina JH 1995). UAE has been 
established as a minimally invasive method for addressing 
uterine related disorders (Edwards RD 2007). Further, a 
recent study stated that the satisfaction rates of the patients 
after UAE were similar to those with patients undergoing 
hysterectomy and myomectomy (Gupta JK 2012), although 
UAE was associated with shorter admission period and 
quicker resumption of daily activities (Jun F 2014). 
       However, no study has been conducted on the efficacy 
of UAE in Iran and further, on its effects with regard to 
fertility considering hormonal levels, ovaries volume and 
follicles. Therefore, the aim of the present study was to 
compare the efficacy of new endovascular treatment (selec-
tive UAE) on women with intrauterine myoma of 4 cm or 
more and its effectiveness in preserving fertility.
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MATERIALS AND METHODS 
Subjects
This cross-sectional study was conducted from July 2016 to 
May 2018 and all the patients referred for uterine leiomyo-
ma, were assessed for UAE. During this process, all the 
patients were informed about the possible uterine leiomyo-
ma complications, its associated effects on fertility and 
pregnancy, as well as available present-day treatments and 
their advantages and disadvantages. Patients were observed 
during the entire study and had the right to withdraw further 
evaluation at any time.  The ethical aspect of this study was 
confirmed by the associated ethical committee. Inclusion 
criteria were: age under 40 years, patients who had previous 
uterine surgery or were at risk of hysterectomy with surgery 
for leiomyoma, planning for future pregnancy, ultrasound 
confirmation of the leiomyoma, at least 4 cm in the largest 
diameter inside the uterus (in the case of more than one 
leiomyoma, the largest with at least 4 cm in diameter was 
considered) and serum follicle-stimulating hormone (FSH) 
levels below 30 IU/L on the 3rd day of the menstrual cycle. 
Exclusion criteria were: pedunculated fibroma with thin 
pedicle (which is less than 50% of largest diameter of 
myoma), the size of myomatous uterus greater than the 
uterus size of 24 weeks of gestation (unless the purpose of 
UAE is leiomyoma debulking before myomectomy 
surgery), the size of the intracavity portion of the fibroma 
more than 3 cm, and ultimately virgin patients. 
Sonography
All surveys were performed by the same radiologist using a 
curved probe of 3.5-5.5 MHz and   endovaginal probe of 6.5 
MHz in a high-resonance scanner. The size of the fibroid 
was calculated according to the previous studies (Orsini LF 
1984). 
Hormonal Assay 
For hormonal assays, blood sample (10 cc) of venous vein 
was taken in the morning to assay FSH, luteinizing hormone 
(LH) and estradiol on the 3rd day of menstrual cycle, before 
UAE and also 6 months after UAE. The hormonal assay of 
these hormones is done with a solid phase enzyme-linked 
immunosorbent assay (ELISA).
Statistical Analysis 
Chi-square test was used to compare qualitative data. All 
statistical analysis of the data was performed by SPSS 19 
(SPSS Inc., Chicago, USA) software. A p- value <0.05 was 
considered significant.
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(Abbreviations; BMI: body mass index)
Table 2. Characteristics of patients
Variable Mean ±SD                      Range 
Age (year) 25-4036.13±2.3
22-2724.53±3.54
0-41.6±1.2
0-41.1±1.2
BMI (kg/m2)
Gravity (n)
Parity (n)
IIMMIN 4(2) 1- 5
RESULTS
In our study, thirty women patients with leiomyoma were 
enrolled. Characteristics of these patients are illustrated in 
table 1. With regard to hypermenorrhea; 6 cases (20%) were 
without, 4 cases (13.3%) with mild, 5 cases (16.66%) with 
moderate and about 15 cases (50%) with severe hypermenor-
rhea were detected. After UAE, the cases of hypermenorrhea 
decreased significantly (p=0.031). Around 28 cases 
(93.33%) were without and 2 cases (6.66%) were with mild 
severity of hypermenorrhea. Furthermore, no cases of moder-
ate and severe hypermenorrhea were noticed. 
In the case of dysmenorrhea, 8 cases (26.66%) were without, 
3 cases (10%) with mild, 2 cases (6.66%) with moderate and 
around 17 cases (56.66%) with severe dysmenorrhea were 
detected. However, after UAE, 26 (86.66%) cases were 
without, 2 cases (6.66%) with mild and 2 cases (6.66%) with 
moderate dysmenorrhea were identified. Again, no case of 
severe dysmenorrhea was present. Hence, the number of 
dysmenorrhea cases decreased significantly after UAE 
(p=0.001). 
    About dyspareunia, 17 cases (56.66%) were without, 3 
cases (10%) with mild, 6 cases (20%) with moderate and 4 
cases (13.33%) with severe dyspareunia were detected. 
After UAE, the cases were 26 (86.66%) without, 2 cases 
(6.66%) with mild and further 2 cases (6.66%) with moder-
ate dyspareunia were noticed. There was no case of severe 
dyspareunia present (p=0.000).  
    With regard to the pelvic pain, 16 cases (53.33%) were 
without, 2 cases (6.66%) with mild, 2 cases (6.66%) with 
moderate and 10 cases (33.33%) with severe pelvic pain 
were recognized. After UAE, 28 cases (93.33%) were 
without and 2 cases (6.66%) were with mild pelvic pain and 
there were no case of moderate and severe pelvic pain 
(p=0.024). 
  About dysuria, 20 cases (66.66%) were without, 6 cases 
(20%) with mild, 2 cases (6.66%) with moderate and 2 cases 
(6.66%) with severe dysuria were detected. After UAE, 27 
cases (90%) were without and 2 cases (6.66%) with mild, 
and 1 case (3.33%) with moderate dysuria was noticed. 
There were no case of severe pelvic pain (p=0.000). Illustrat-
ed in table 2.
  Frequency distribution of recovery time and return to 
routine activity after UAE, for less than 10 days, 10 to 30 
days and more than 30 days were 59, 27, and 12, respective-
ly. Illustrated in figure 1.
(Abbreviations; UAE: uterine artery embolization) (Abbreviations; UAE: uterine artery embolization)
(Abbreviations; UAE: uterine artery embolization)
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Table 2. The mean and standard deviation before and after UAE
Variable before UAE after UAE P-value
2
2
0.031Hypermenorrhea without 6
4
0
mild
5
0
26
moderate
severe 15
8
23
22
0.001
Dysmenorrhea without
mild
moderate
severe
Dyspareunia without
mild
moderate
severe
Pelvic pain without
mild
moderate
severe
Dysuria without
mild
moderate
severe
017
26
2
17
3
26
0
28
4
16
22
02
0
27
2
1
0
20
6
2
2
10
0.000
0.024
0.000
A review of the frequency distribution of complications 
showed that UAE did not result in serious complications 
among patients. None of the patients showed complications 
such as embolism, hysterectomy or wound problems. 
However, some issues such as infection (6.7%), hematoma 
(1.8%), bleeding (2.4%) and pain (20%) were observed 
among the patients. Illustrated in fig 2. 
      Considering effects on hormonal changes and sonogra-
phy of leiomyoma , UAE did not show significant changes 
with regard to hormonal levels, and the mean and standard 
deviation of FSH levels before the UAE was 15.64 ± 3.23 
mIU/mL and 6 months after UAE was 16.83 ± 4.21 
mIU/mL, (p=0.431). The level of LH before UAE was 12.64 
± 4.65 mIU/mL and 6 months after UAE was 14.32 ± 3.65 
mIU/mL (p=0.672). Finally, the level of estradiol before 
UAE was 16.3 mIU/mL and 6 months after UAE was 18.51 
Effect of Uterine Artery Embolization on Leiomyoma
Fig 2. Frequency distribution of complications after UAE.Fig 1. Frequency distribution of recovery duration after 
UAE.
Table 3. The mean and standard deviation sex hormones 
before and after UAE
Variable Before UAE After UAE P-value
FSH 16.83
14.32
18.51
15.64
12.64
16.3
0.431
0.672
0.772
LH
Estradiol
(Abbreviations; UAE: uterine artery embolization, FSH: follicle-
stimulating hormone, LH: luteinizing hormone)
(Abbreviations; UAE: uterine artery embolization)
4 IIMMIN 4(2) 1- 5
mIU/mL (p=0.772) Henceforth, no significant difference 
was observed. Illustrated in table 3.
      Before UAE, size of myoma was 86.47 ± 28.42 cm and 
6 months after UAE, the size decreased significantly to 
59.80 ± 20.90 cm (p=0.000). Illustrated in figure 3.
Fig 3. Mean and standard deviation of myoma size before 
and after UAE. 
DISCUSSION
The purpose of the present study was to evaluate the effects 
of UAE on reducing the size of fibroids and possible compli-
cations of this technique. We also studied the effects of UAE 
on fertility among women with leiomyoma. Till today, 
considerable research studies have focused on  variety of 
therapeutic techniques and the effects of these on symptom 
control, fibroid size reduction, possible complications, and 
fertility (Zhang HX 2012). We assessed these factors in 30 
women patients with leiomyoma. Most of the patients in our 
study were in the reproductive age, with an average age of 
36.13 years. The mean body mass index (BMI) was 24.45 
kg/m2, indicating that the patients were not obese. Both age 
and obesity are important factors, in the occurrence of 
leiomyoma and its prognosis. Among the women with 
leiomyoma who are younger than 40 years, maintaining 
fertility during the treatment is one of the most important 
outcomes. Most studies have shown that UAE is a success-
ful technique for managing leiomyoma amidst women of 
reproductive age, with high pregnancy rates later. 
We noticed that UAE did not affect the level of sex 
hormones, 6 months after the procedure. Hence, these 
results suggested that unlike other surgical procedures, UAE 
did not interfere with the fertility in women. Our results 
were consistent with the previous findings. In one study, the 
rates of ovarian failure following UAE (11%) and surgical 
methods (18%) were not found to be significantly different, 
12 months after the surgery (Rashid S 2010). Additionally, 
there was no significant difference in the level of FSH and 
prostaglandin E2 hormones before and after 3, 6 and 12 
months of UAE (Tropeano G 2003). Contrarily, some 
studies have reported that UAE is associated with persistent 
ovarian failure (Orsini LF 1984; Zhang HX 2012; Rashid S 
2010; Tropeano G 2003). Some other studies have reported 
occurrence of infertility, following UAE (Ravina JH 1995; 
Edwards RD 2007; Jun F 2014; Orsini LF 1984; Zhang HX 
2012; Rashid S 2010; Tropeano G 2003; Chrisman HB 
2000; Spies JB 2001; Firouznia K 2013; Volkers NA 2007). 
Besides, it has been  hypothesized that UAE may cause 
ovarian hypoxia, ischemia and subsequent ovarian failure 
(Spies JB 2001). Extensive studies have been conducted 
about the success rate of UAE in controlling leiomyoma 
symptoms.  UAE significantly reduced symptoms and 
improved quality of life in women with leiomyoma over a 
period of 3 years (Goodwin). When hysterectomy was 
compared with UAE in the treatment of uterine fibroids, the 
results showed no significant difference in controlling pain 
and bulk-related symptoms (Volkers NA 2007). The 
inconsistency of these results with other research findings 
was attributed to the severity of the symptoms and history of 
medical and surgical procedures that made hysterectomy the 
most suitable approach in that study (Volkers NA 2007). 
Nonetheless, in the present study, besides  controlled 
symptoms after UAE, none of the patients required hysterec-
tomy. However, certain complications such as infection 
(6.4%), hematoma (1.8%), bleeding (2.4%) and pain (20%) 
were seen among the patients. Previous studies have 
revealed that the rate of post-operative complications, such 
as infection, wound problems, and need for re-intervention 
in UAE group was 16% while in the patients with hysterecto-
my it was 25% (Moss JG  2011). In a review and meta-analy-
sis study, it was concluded that the satisfaction rate of the 
patients with UAE was significantly higher than those 
patients who underwent surgery (Gupta JK 2012). The signif-
icant reduction in myoma size noticed in our study was 
similar to that observed in other studies. In a study by 
Watson et al, 114 patients showed a 58% reduction in 
fibroids (McLucas B 1999). Similarly, another study 
concluded that UAE was an excellent technique for 
controlling symptoms and  also had high efficacy in 
reducing fibroids (Walker WJ 2002). Finally, we have 
shown that fertility indices measured as the levels of estradi-
ol, FSH and LH hormones did not differ significantly before 
and after UAE. However, one of the limitations of our study 
is that we did not compare the results of hysterectomy with 
UAE.   Also, we recommend longer follow-up of patients to 
detect probable side effects of  UAE. 
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